Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2014

View Archived Issues

Bayer presents first-in-human and promising in vivo data for BAY-85-8501

Discovery of novel allosteric GSK-3 inhibitors for the treatment of neurodegenerative diseases

Sanofi and MyoKardia form collaboration to develop treatments for genetic cardiomyopathies

Genzyme product receives orphan designation for Gaucher's disease

Legalon Sil given FDA orphan designation for amatoxin poisoning

BA-321, a selective androgen receptor modulator for treatment of male osteoporosis

Cell Cure Neurosciences shows safety and efficacy of OpRegen in animal studies

Metabolon partners with Metdia for European commercialization of prediabetes tests

Sutro Biopharma and Merck KGaA establish ADC collaboration agreement

Glenmark completes phase IIa study of TRPA1 receptor antagonist

USP7 gene polymorphisms linked to breast cancer susceptibility in Chinese women

World Alzheimer's Day: Research efforts towards early diagnosis and new therapeutic strategies

Research looks into role of betatrophin in human diabetes and its potential as a biomarker

Shionogi discloses novel AMPK activators for diabetes

Avraham Pharmaceuticals raises additional funding to advance ladostigil development

Mochida Pharmaceutical synthesizes new PDE10 inhibitors

Janssen patents novel compounds for HBV infection

Scientists at Bristol-Myers Squibb disclose new agents for cancer

Therabiol divulges new vaccines for HIV infection

Pocket consortium updates on tuberculosis diagnostic device

Zydelig approved in E.U. for chronic lymphocytic leukemia and follicular lymphoma

Fred Hutchinson Cancer Research Center receives grant to run infection epidemiology center

Umecrine Mood reports results from phase I/II trial of UC-1010

Japanese approval of Eylea for myopic choroidal neovascularization

Nuvilex advances Cell-in-a-Box programs for pancreatic cancer and diabetes

Qu Biologics closes private financing

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...